<DOC>
	<DOC>NCT01132417</DOC>
	<brief_summary>Observational: studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.</brief_summary>
	<brief_title>In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance</brief_title>
	<detailed_description>Study Phase Definition: Phase of investigation, as defined by the US FDA for trials involving investigational new drugs. Select only one. N/A: for trials without phases Observational Study Design Case-control: group of individuals with specific characteristics (e.g., conditions or exposures) compared to group(s) with different Time Perspective Cross-sectional: observations or measurements made at a single point in time, usually at subject enrollment Biospecimen Retention - select one Samples Without DNA - samples retained, with no potential for DNA extraction from any retained samples (e.g., fixed tissue, plasma) Biospecimen Description Sputum, whole blood, urine, tissue Enrollment Single group study Number of Groups/Cohorts Definition: Number of study groups/cohorts. Enter 1 for a single-group study. Many observational studies have one group/cohort; case control studies typically have two. One study group, anticipated samples in the rang of 400-500 samples 8. Arms, Groups and Interventions N/L Group/Cohort Label</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>All patients with infection with MDRs infections will be included</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Tigecycline, MDR</keyword>
	<keyword>Patient infected with multidrug resistance bacteria</keyword>
</DOC>